TrialClinical pharmacokinetics2017

Population Pharmacokinetics and Immunogenicity of Adalimumab in Adult Patients with Moderate-to-Severe Hidradenitis Suppurativa.

Ahmed Nader et al.PubMed ↗Publisher ↗

No numbers read from the abstract.